JustPaste.it

Canada Myocardial Infarction Market Trends, Growth, Analysis and Forecast 2022-2028

Canada myocardial infarction market is estimated to grow modestly at a CAGR of around 8.3% during the forecast period. Canada has a considerable market of myocardial infarction treatment due to the presence of a huge patient pool suffering from persisting heart diseases such as CVD, CHD, stroke, hypertension, and other heart diseases. Canada contributes significantly to the MI treatment market due to the huge investment of government in healthcare facilities, R&D, and the adoption of innovative technologies in the healthcare domain. According to the Canadian Institute of Health Research, more than 1.6 million Canadians are suffering from heart disease. It is the second-leading cause of mortality in Canada after cancer. Nine in 10 Canadians over the age of 20 have at least one risk factor involving heart disease. Many health charities invest millions of dollars in research, health promotion, and community programs in Canada. For instance, the Heart and Stroke foundation invested more than $91 million in R&D of heart diseases and surgeries. 

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/canada-myocardial-infarction-market

The market is segmented into type, device, diagnosis, treatment, and end-user. Based on type, the market is segmented into ST-elevation myocardial infarction (STEMI) heart attacks, non-ST elevation myocardial infarction (NSTEMI) heart attacks, and silent heart attacks. Based on the device, the market is segmented into left ventricular assist device, pacemaker, implantable cardioverter defibrillator, and others (aspiration-based catheters). Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest X-Ray, Computed Tomography (CT Scan), echocardiography, and others (blood test). Based on treatment the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs), and research institutes.

The companies which are contributing to the growth of the Canada myocardial infarction market include Abbott Laboratories Inc., Johnson & Johnson Services Inc., Mylan N.V., Pfizer Inc., Bayer AG, and Novartis AG. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. 

A full report of Canada Myocardial Infarction Market available@ https://www.omrglobal.com/industry-reports/canada-myocardial-infarction-market

Canada Myocardial Infarction Market Segmentation

By Type

  • Non-ST-elevation myocardial infarction (NSTEMI)
  • ST-elevation myocardial infarction (STEMI)
  • Silent Heart Attacks

By Device           

  • Left Ventricular Assist Device (LVAD) 
  • Pacemaker
  • Catheters
  • Implantable Cardioverter-Defibrillator (ICD)
  • Others (Stent Graft)

By Diagnosis     

  • Electrocardiography (ECG) 
  • Chest X-Ray
  • Computed Tomography (CT Scan)
  • Echocardiography
  • Others (Blood Test)

By Treatment   

  • Medication
  • Analgesics
  • Thrombolytic
  • Antiplatelet Agents
  • Glycoprotein IIb/IIIa Inhibitors
  • Others (Beta-Adrenergic Blockers)
  • Surgery
  • Angioplasty
  • Bypass Surgery
  • Heart Transplant

By End-Users

  • Hospital & Clinics
  • Ambulatory Surgical Centers
  • Research Institutes

Company Profiles

  • Abbott Laboratories Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Boston Scientific Corp.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.

Reasons to Buying From us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

 

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research